NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024GlobeNewsWire • Thursday
NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024GlobeNewsWire • 08/27/24
NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024GlobeNewsWire • 08/13/24
NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit DisclosureGlobeNewsWire • 06/07/24
NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024GlobeNewsWire • 05/21/24
NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024GlobeNewsWire • 05/15/24
NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024GlobeNewsWire • 04/01/24
NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center RegistryGlobeNewsWire • 03/27/24
NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceGlobeNewsWire • 02/27/24
NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive OfficerGlobeNewsWire • 12/20/23
NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal DeviceGlobeNewsWire • 11/08/23